| 101738-3 |
Platelet aggregation.ristocetin induced^250 ug/mL |
RelACnc |
PRP |
Pt |
Qn |
|
|
ACTIVE |
Platelet aggregation ristocetin induced in Platelet rich plasma --250 ug/mL |
|
ADD |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
COAG |
|
101738-3 |
|
|
|
|
Both |
|
|
|
0 |
PA Rist 250 ug/mL PRP |
|
|
|
N |
|
Agg; Aggr; COAGULATION; mcg; PA; PA Rist; Pl; Platelet rich plasma; Platelets; Platelt; Plt; Point in time; QNT; Quan; Quant; Quantitative; Random; RIPA; RlACnc; Thrombocyte; Thrombocytes |
2.75 |
2.75 |
|
|
|
|
|
|
|
% |
|
|
|
0 |
| 101739-1 |
Platelet aggregation.ristocetin induced^125 ug/mL |
RelACnc |
PRP |
Pt |
Qn |
|
|
ACTIVE |
Platelet aggregation ristocetin induced in Platelet rich plasma --125 ug/mL |
|
ADD |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
COAG |
|
101739-1 |
|
|
|
|
Both |
|
|
|
0 |
PA Rist 125 ug/mL PRP |
|
|
|
N |
|
Agg; Aggr; COAGULATION; mcg; PA; PA Rist; PA Rist 125 ug/mL; Pl; Platelet rich plasma; Platelets; Platelt; Plt; Point in time; QNT; Quan; Quant; Quantitative; Random; RIPA; RlACnc; Thrombocyte; Thrombocytes |
2.75 |
2.75 |
|
|
|
|
|
|
|
% |
|
|
|
0 |
| 10174-1 |
Symptoms & diseases |
Hx |
Nose |
Pt |
Nar |
|
|
ACTIVE |
History of Nose disorders Narrative |
|
NAM |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
H&P.HX |
|
10174-1 |
|
|
|
|
|
|
|
|
0 |
Hx of Nose disorders |
|
|
|
|
|
H+P; H+P.HX; History; Narrative; Nasal; Nos; Nose (nasal passage); P prime; Point in time; Random; Report; Smell; Sx; Symp + dis |
2.56 |
1.0i |
|
|
|
|
|
|
|
|
|
|
Removed "History of" from Component, changed Property from "Find" to "Hx", and removed "Reported" Method per 8/2015 Clinical LOINC Committee decision |
0 |
| 101740-9 |
3-Hydroxy-3-Methylglutaryl-Coenzyme A reductase Ab |
RelACnc |
Ser |
Pt |
Qn |
IA |
|
ACTIVE |
3-Hydroxy-3-Methylglutaryl-coenzyme A reductase Ab in Serum by Immunoassay |
|
ADD |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
SERO |
|
101740-9 |
|
IA |
|
|
Observation |
|
|
|
0 |
HMGCR Ab Ser IA |
|
|
|
N |
|
3-OH-3-Methylglutaryl-coA reductase Ab; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; HMGCR; Hydrox; IAA; III; MEIA; NAM; Necrotizing autoimmune myopathy; OH; Point in time; QNT; Quan; Quant; Quantitative; Random; RlACnc; Serology; Serum; SR; SUDS |
2.75 |
2.75 |
|
|
|
|
|
|
|
% |
|
|
|
0 |
| 101741-7 |
Nonspermatozoal cells |
Naric |
Semen |
Pt |
Qn |
Microscopy.light.HPF |
|
ACTIVE |
Nonspermatozoal cells [#/area] in Semen by Microscopy high power field |
|
ADD |
DefinitionDescription |
|
|
/[HPF] |
|
|
|
|
|
|
FERT |
|
101741-7 |
|
Microscopy.light.HPF |
|
|
Both |
|
|
|
0 |
NSC #/area Smn HPF |
|
|
|
N |
|
#/area; Cell; Cellularity; Ejaculate; FERTILITY TESTING; LM; Micro; Micros; Microscopic; NSC; Number areic; Point in time; QNT; Quan; Quant; Quantitative; Random; Sem; Seminal fluid; Smn; SMPLS |
2.75 |
2.75 |
|
|
|
|
|
|
|
/[HPF] |
|
|
|
0 |
| 101742-5 |
Mitochondria M2-3E Ab |
PrThr |
Ser |
Pt |
Ord |
|
|
ACTIVE |
Mitochondria M2-3E Ab [Presence] in Serum |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SERO |
|
101742-5 |
|
|
|
|
Both |
|
|
|
0 |
M2-3E Ab Ser Ql |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; BPO; Microtubule Associated Protein 2; Mito; Mitochon; Mitochond; Mitochondrial; Mitochondrial m2; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Serum; SR |
2.75 |
2.75 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 101743-3 |
PML Ab |
PrThr |
Ser |
Pt |
Ord |
|
|
ACTIVE |
PML Ab [Presence] in Serum |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SERO |
|
101743-3 |
|
|
|
|
Observation |
|
|
|
0 |
PML Ab Ser Ql |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; MYL; Ordinal; PML-1; PML-2; PML-3; PML-3B; PML-X; Point in time; PR; Promyelocytic leukemia; QL; Qual; Qualitative; Random; Screen; Serology; Serum; SR |
2.75 |
2.75 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 101744-1 |
Toxoplasma gondii DNA |
PrThr |
Plas |
Pt |
Ord |
Probe.amp.tar |
|
ACTIVE |
Toxoplasma gondii DNA [Presence] in Plasma by NAA with probe detection |
|
MAJ |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
101744-1 |
|
Probe.amp.tar |
|
|
Both |
|
|
|
0 |
T gondii DNA Plas Ql NAA+probe |
|
|
|
N |
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Pl; Plasma; Plsm; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; T gondii; T gondii DNA; TMA; Toxo; Toxoplasmosis; Transcription mediated amplification |
2.76 |
2.75 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 101745-8 |
Dipeptidyl aminopeptidase-like protein 6 Ab |
PrThr |
Ser |
Pt |
Ord |
CBA IFA |
|
ACTIVE |
Dipeptidyl aminopeptidase-like protein 6 Ab [Presence] in Serum by Cell binding immunofluorescent assay |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
101745-8 |
|
CBA IFA |
|
|
Both |
|
|
|
0 |
DPPX Ab Ser Ql CBA IFA |
|
|
|
N |
|
ABS; Aby; Amiopep; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dipeptidyl peptidase-like protein 6; Dipeptidyl peptidase-like protein 6 Ab; DPPX; DPPX Ab; Indirect Fluorescence Antibody; Microbiology; Ordinal; Point in time; PR; Prot; QL; Qual; Qualitative; Random; Screen; Serum; SR |
2.75 |
2.75 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 101746-6 |
Purkinje cell cytoplasmic type Tr Ab |
PrThr |
Ser |
Pt |
Ord |
CBA IFA |
|
ACTIVE |
PCA-Tr Ab [Presence] in Serum by Cell binding immunofluorescent assay |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
101746-6 |
|
CBA IFA |
|
|
Both |
|
|
|
0 |
PCA-Tr Ab Ser Ql CBA IFA |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cytopl; Cytoplas; Hodgkin's lymphoma; Indirect Fluorescence Antibody; Limbic encephalopathy; Microbiology; Ordinal; Paraneoplastic cerebellar degeneration; Paraneoplastic neurological syndrome; Paraneoplastic syndrome; PCD; PNS; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR |
2.75 |
2.75 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 101747-4 |
Purkinje cell cytoplasmic type Tr Ab |
Titr |
Ser |
Pt |
SemiQn |
CBA IFA |
|
ACTIVE |
PCA-Tr Ab [Titer] in Serum by Cell binding immunofluorescent assay |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
101747-4 |
|
CBA IFA |
|
|
Both |
|
|
|
0 |
PCA-Tr Ab Titr Ser CBA IFA |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cytopl; Cytoplas; Dilution factor; Dilution Factor (Titer); Hodgkin's lymphoma; Indirect Fluorescence Antibody; Limbic encephalopathy; Microbiology; Paraneoplastic cerebellar degeneration; Paraneoplastic neurological syndrome; Paraneoplastic syndrome; PCD; PNS; Point in time; Random; Serum; SmQn; SR; Titer; Titered; Titre; Ttr |
2.76 |
2.75 |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
| 101748-2 |
Maraviroc anticipated activity |
Find |
Bld |
Pt |
Ord |
Probe.amp.tar |
|
ACTIVE |
Maraviroc anticipated activity in Blood Qualitative by RT-PCR |
|
MAJ |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
101748-2 |
|
Probe.amp.tar |
|
|
Both |
|
|
|
0 |
Maraviroc anticipated act Bld Ql |
|
|
|
N |
|
3 Self-Sustaining Sequence Replication; 3SR SR; Activ; Actvty; Amplif; Amplification; Amplified; Blood; DNA NUCLEIC ACID PROBE; DNA probe; Finding; Findings; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Movements; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; WB; Whole blood |
2.76 |
2.75 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 101749-0 |
Borrelia miyamotoi DNA |
PrThr |
Bld |
Pt |
Ord |
Probe.amp.tar |
|
ACTIVE |
Borrelia miyamotoi DNA [Presence] in Blood by NAA with probe detection |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
101749-0 |
|
Probe.amp.tar |
|
|
Both |
|
|
|
0 |
B miyamotoi DNA Bld Ql NAA+probe |
|
|
|
N |
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; B miyamotoi; B miyamotoi DNA; Blood; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TBRF; Tick Borne Diseases; tick-borne relapsing fever; TMA; Transcription mediated amplification; WB; Whole blood |
2.75 |
2.75 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 10175-8 |
Symptoms & diseases |
Hx |
Oral cavity |
Pt |
Nar |
|
|
ACTIVE |
History of Oral cavity disorders Narrative |
|
NAM |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
H&P.HX |
|
10175-8 |
|
|
|
|
|
|
|
|
0 |
Hx of Oral cavity disorders |
|
|
|
|
|
Dental; H+P; H+P.HX; History; Mouth; Mouth+throat+teeth; Narrative; P prime; Point in time; Random; Report; Sx; Symp + dis |
2.56 |
1.0i |
|
|
|
|
|
|
|
|
|
|
Removed "History of" from Component, changed Property from "Find" to "Hx", and removed "Reported" Method per 8/2015 Clinical LOINC Committee decision |
0 |
| 101750-8 |
Adeno-associated virus (AAV) serotype Rh74 |
PrThr |
Ser |
Pt |
Ord |
IA |
|
ACTIVE |
Adeno-associated virus (AAV) serotype Rh74 [Presence] in Serum by Immunoassay |
|
MAJ |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
101750-8 |
|
IA |
|
|
Both |
|
|
|
0 |
AAV serotype rh74 Ser Ql IA |
|
|
|
N |
|
AAVrh74; Assoc; AVV serotype Rh74; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; MEIA; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; SUDS |
2.76 |
2.75 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 101751-6 |
Lithium |
SCnc |
Bld |
Pt |
Qn |
Inductively Coupled Plasma/Optical Emission Spectrometry (ICP/OES) |
|
ACTIVE |
Lithium [Moles/volume] in Blood by Inductively Coupled Plasma/Optical Emission Spectrometry (ICP/OES) |
|
MAJ |
DefinitionDescription |
|
|
mEq/L |
|
|
|
|
|
|
DRUG/TOX |
|
101751-6 |
|
Inductively Coupled Plasma/Optical Emission Spectrometry (ICP/OES) |
|
|
Both |
|
|
|
0 |
Lithium Bld ICP/OES-sCnc |
|
|
|
N |
|
Blood; DRUG/TOXICOLOGY; Drugs; Eskalith; Level; Li; Lithane; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; WB; Whole blood |
2.79 |
2.75 |
|
|
|
|
|
|
|
meq/L |
|
|
Release 2.79: SYSTEM: Correction to an agreed upon representation.; |
0 |
| 101752-4 |
Tau protein/Tau protein.phosphorilated 181 |
MRto |
CSF |
Pt |
Qn |
|
|
ACTIVE |
Tau protein/Tau protein.phosphorilated 181 [Mass Ratio] in Cerebral spinal fluid |
|
ADD |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
CHEM |
|
101752-4 |
|
|
|
|
Both |
|
|
|
0 |
Tau Prot/p-tau181 MRto CSF |
|
|
|
N |
|
Alzheimer disease; Alzheimer's disease; Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Mass concentration ratio; Mass ratio; MCRto; Point in time; PR; Prot; p-tau181; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Tau prot/Tau prot.phos 181 |
2.75 |
2.75 |
|
|
|
|
|
|
|
% |
|
|
|
0 |
| 101753-2 |
Dermatophytes DNA |
PrThr |
XXX |
Pt |
Ord |
Probe.amp.tar |
|
ACTIVE |
Dermatophytes DNA [Presence] in Specimen by NAA with probe detection |
|
NAM |
DefinitionDescription |
|
|
pos/neg |
|
|
|
|
|
|
MICRO |
|
101753-2 |
|
Probe.amp.tar |
|
|
Both |
|
|
|
0 |
Dermatophytes DNA Spec Ql NAA+probe |
|
|
|
N |
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified |
2.76 |
2.75 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 101754-0 |
Trichophyton tonsurans DNA |
PrThr |
XXX |
Pt |
Ord |
Probe.amp.tar |
|
ACTIVE |
Trichophyton tonsurans DNA [Presence] in Specimen by NAA with probe detection |
|
NAM |
DefinitionDescription |
|
|
pos/neg |
|
|
|
|
|
|
MICRO |
|
101754-0 |
|
Probe.amp.tar |
|
|
Both |
|
|
|
0 |
T. tonsurans DNA Spec Ql NAA+probe |
|
|
|
N |
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Spec; Strand Displacement Amplification; T. tonsurans; T. tonsurans DNA; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified |
2.76 |
2.75 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 101755-7 |
Trichophyton equinum DNA |
PrThr |
XXX |
Pt |
Ord |
Probe.amp.tar |
|
ACTIVE |
Trichophyton equinum DNA [Presence] in Specimen by NAA with probe detection |
|
NAM |
DefinitionDescription |
|
|
pos/neg |
|
|
|
|
|
|
MICRO |
|
101755-7 |
|
Probe.amp.tar |
|
|
Both |
|
|
|
0 |
T. equinum DNA Spec Ql NAA+probe |
|
|
|
N |
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Spec; Strand Displacement Amplification; T. equinum; T. equinum DNA; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified |
2.76 |
2.75 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 101756-5 |
Trichophyton interdigitale DNA |
PrThr |
XXX |
Pt |
Ord |
Probe.amp.tar |
|
ACTIVE |
Trichophyton interdigitale DNA [Presence] in Specimen by NAA with probe detection |
|
NAM |
DefinitionDescription |
|
|
pos/neg |
|
|
|
|
|
|
MICRO |
|
101756-5 |
|
Probe.amp.tar |
|
|
Both |
|
|
|
0 |
T. interdigitale DNA Spec Ql NAA+probe |
|
|
|
N |
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Spec; Strand Displacement Amplification; T. interdigitale; T. interdigitale DNA; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified |
2.76 |
2.75 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 101757-3 |
Trichophyton mentagrophytes DNA |
PrThr |
XXX |
Pt |
Ord |
Probe.amp.tar |
|
ACTIVE |
Trichophyton mentagrophytes DNA [Presence] in Specimen by NAA with probe detection |
|
MAJ |
DefinitionDescription |
|
|
pos/neg |
|
|
|
|
|
|
MICRO |
|
101757-3 |
|
Probe.amp.tar |
|
|
Both |
|
|
|
0 |
T ment DNA Spec Ql NAA+probe |
|
|
|
N |
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; m37; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Spec; Strand Displacement Amplification; T ment; T mentagrophytes; T.mentagrophytes DNA; TMA; To be specified in another part of the message; Transcription mediated amplification; Trichophyton ment; Unspecified |
2.76 |
2.75 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 101758-1 |
Trichophyton quinckeanum DNA |
PrThr |
XXX |
Pt |
Ord |
Probe.amp.tar |
|
ACTIVE |
Trichophyton quinckeanum DNA [Presence] in Specimen by NAA with probe detection |
|
NAM |
DefinitionDescription |
|
|
pos/neg |
|
|
|
|
|
|
MICRO |
|
101758-1 |
|
Probe.amp.tar |
|
|
Both |
|
|
|
0 |
T. quinckeanum DNA Spec Ql NAA+probe |
|
|
|
N |
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Spec; Strand Displacement Amplification; T. quinckeanum; T. quinckeanum DNA; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified |
2.76 |
2.75 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 101759-9 |
Trichophyton schoenleinii DNA |
PrThr |
XXX |
Pt |
Ord |
Probe.amp.tar |
|
ACTIVE |
Trichophyton schoenleinii DNA [Presence] in Specimen by NAA with probe detection |
|
NAM |
DefinitionDescription |
|
|
pos/neg |
|
|
|
|
|
|
MICRO |
|
101759-9 |
|
Probe.amp.tar |
|
|
Both |
|
|
|
0 |
T. schoenleinii DNA Spec Ql NAA+probe |
|
|
|
N |
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Spec; Strand Displacement Amplification; T. schoenleinii; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified |
2.76 |
2.75 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 10176-6 |
Symptoms & diseases |
Hx |
Reproductive system |
Pt |
Nar |
|
|
ACTIVE |
History of Reproductive system disorders Narrative |
|
NAM |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
H&P.HX |
|
10176-6 |
|
|
|
|
|
|
|
|
0 |
Hx of Reproductive disorders |
|
|
|
|
|
H+P; H+P.HX; History; Narrative; P prime; Point in time; Random; Report; Sx; Symp + dis |
2.56 |
1.0i |
|
|
|
|
|
|
|
|
|
|
Removed "History of" from Component, changed Property from "Find" to "Hx", and removed "Reported" Method per 8/2015 Clinical LOINC Committee decision |
0 |
